Cited by 1,860Angiogenesis and VEGF in CancerLymphatic System and DiseasesCancer Cells and Metastasis

Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

Lyden, David, Hattori, Koichi, Dias, Sergio, Costa, Carla, Blaikie, Pamela, Butros, Linda, Chadburn, Amy, Heissig, Beate +12 more·2001·Nature Medicine

Abstract

The role of bone marrow (BM)-derived precursor cells in tumor angiogenesis is not known. We demonstrate here that tumor angiogenesis is associated with recruitment of hematopoietic and circulating endothelial precursor cells (CEPs). We used the angiogenic defective, tumor resistant Id-mutant mice to show that transplantation of wild-type BM or vascular endothelial growth factor (VEGF)-mobilized stem cells restore tumor angiogenesis and growth. We detected donor-derived CEPs throughout the neovessels of tumors and Matrigel-plugs in an Id1+/-Id3-/- host, which were associated with VEGF-receptor-1-positive (VEGFR1+) myeloid cells. The angiogenic defect in Id-mutant mice was due to impaired VEGF-driven mobilization of VEGFR2+ CEPs and impaired proliferation and incorporation of VEGFR1+ cells. Although targeting of either VEGFR1 or VEGFR2 alone partially blocks the growth of tumors, inhibition of both VEGFR1 and VEGFR2 was necessary to completely ablate tumor growth. These data demonstrate that recruitment of VEGF-responsive BM-derived precursors is necessary and sufficient for tumor angiogenesis and suggest new clinical strategies to block tumor growth.

Integrity signals

Registry

Crossref · 10.1038/nm1101-1194

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • BMDCs promote metastasis by producing chemokines that recruit tumor cells to the lung by mechanisms that include stimulation of tumor cell extravasation.

    “The BMDCs promote metastasis by producing chemokines that recruit tumor cells to the lung by mechanisms that include stimulation of tumor cell extravasation”

    From Hypoxic control of metastasis (2016) · cites this paper as [94]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., Wu, Y., Hicklin, D., Zhu, Z., Hackett, N. R., Crystal, R. G., Moore, M. A. S., Hajjar, K. A., Manova, K., Benezra, R., & Rafii, S.
Affiliations
  • Memorial Sloan Kettering Cancer Center (US)
  • Cornell University (US)
Corresponding author
  • Benezra, Robert
  • Rafii, Shahin
Venue
Nature Medicine
Published
2001-11
Volume
7
Issue
11
Pages
1194-1201
ISSN
  • 1078-8956 (ISSN-L)
  • 1546-170X
OpenAlex
W1485875137
Cited by
1,860
References
29
Citations by year
2026: 5 · 2025: 11 · 2024: 11 · 2023: 23 · 2022: 35 · 2021: 22 · 2020: 25 · 2019: 38 · 2018: 27 · 2017: 49 · 2016: 49 · 2015: 49 · 2014: 72 · 2013: 103 · 2012: 110
FWCI
34.99
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (R01-HL-61849, HL 67839, R01HL061849, HL-66592, P01HL067839)
  • National Cancer Institute (CA08748, P30CA008748)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
tumor angiogenesis, endothelial progenitor cells, hematopoietic progenitor cells, vascular endothelial growth factor, VEGFR1, VEGFR2, tumor growth, myeloid cells, neovascularization, anti-angiogenic therapy
MeSH terms
Animals, DNA-Binding Proteins, Endothelium, Vascular, Hematopoietic Stem Cells, Mice, Inbred C57BL, Mice, Mutant Strains, Mutation, Neoplasm Proteins, Neoplasms, Experimental, Neovascularization, Pathologic, Neutralization Tests, Proto-Oncogene Proteins, Repressor Proteins, Transcription Factors, Receptors, Growth Factor, Mice, Knockout, Hematopoietic Stem Cell Transplantation, Receptor Protein-Tyrosine Kinases, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor-1, Mice, Inhibitor of Differentiation Proteins, Inhibitor of Differentiation Protein 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review